CHEK2 and nonpapillary renal cell carcinoma: Additionally, we provide further evidence for the importance of genetic variation in telomerase maintenance in mediating ccRCC as well as additional support for DNA damage genes, CHEK2 and FANCD2, in disease aetiology (Fig. 4).